Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

298 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Completed

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

NCT04925284

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Exelixis Clinical Site #48 Birmingham, Alabama, United States
  • Exelixis Clinical Site #20 Tucson, Arizona, United States
  • Exelixis Clinical Site#95 Tucson, Arizona, United States
  • Exelixis Clinical Site#58 Little Rock, Arkansas, United States
View all 95 locations
View Trial Details
Completed

Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer

NCT04494958

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Hospital Universitari Arnau de Vilanova de Lleida Lleida, Spain
  • Hospìtal Universitario de la Princesa Madrid, Spain
  • Hospital Ramon y Cajal Madrid, Spain
  • Hospital Clínico San Carlos Madrid, Spain
View Trial Details
Completed

Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid Tumors

NCT03333915

Conditions
Advanced High-grade Ovarian Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View Trial Details
Completed

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

NCT03667716

Conditions
Adnexal Diseases, Advanced Cancer, Breast Cancer, +44 more
Locations
  • University of California Los Angeles (UCLA). Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

NCT03504488

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +24 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope - Duarte Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • California Research Institute Los Angeles, California, United States
View all 59 locations
View Trial Details
Completed

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

NCT03997968

Conditions
Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +68 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
View all 16 locations
View Trial Details
Completed

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

NCT03206203

Conditions
Breast Diseases, Breast Neoplasms, HER2 Negative, +8 more
Locations
  • Georgetown University Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Indiana University Health Melvin Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

NCT03487666

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details

Related conditions